MWCNT Supported by Fe/Cu Bimetallic-based Metal-Organic Frameworks Immobilized with Silver Nanoparticles as a Platform in Electrochemical Immunosensors Fabrication for HER2 Detection in Breast Cancer | Synapse
March 3, 2026
MWCNT Supported by Fe/Cu Bimetallic-based Metal-Organic Frameworks Immobilized with Silver Nanoparticles as a Platform in Electrochemical Immunosensors Fabrication for HER2 Detection in Breast Cancer
Puntos clave
Electrochemical immunosensors demonstrate significant effectiveness in detecting HER2 levels associated with breast cancer.
Utilizing MWCNT supported by bimetallic frameworks successfully improves the sensitivity of immunosensors in detecting biomarkers.
This analysis employs silver nanoparticles within a metal-organic framework to enhance detection capabilities for specific cancer biomarkers.
Findings may enable more efficient and accurate breast cancer diagnostics, highlighting the potential of novel materials in medical applications.